Avident Health LLC and Unite for HER have been awarded a quality improvement grant funded by Pfizer Inc. and the National Comprehensive Cancer Network (NCCN) to enhance care for patients with metastatic breast cancer (mBC). The collaboration will use Avident Health's MyNavigator digital platform to deliver personalized education and connect patients with supportive services.
Metastatic breast cancer requires complex, ongoing treatment management, with adherence, symptom monitoring, and whole-person supportive care being critical. However, patients and their families often struggle to navigate clinical guidelines and access community resources outside of traditional appointments. This initiative aims to address those gaps by providing a home-based, interactive companion that translates NCCN Guidelines for Patients into accessible modules tailored to each patient's treatment journey.
The MyNavigator platform will also streamline access to Unite for HER's free integrative services, including nutrition counseling, fresh food delivery, mental health counseling, and evidence-based therapies. By integrating these services directly into daily navigation prompts, the platform seeks to remove barriers to supportive care. Additionally, the platform engages informal family caregivers by including them in a secure communication loop, ensuring they have the education and early symptom alerting needed to support treatment adherence at home. Patient-reported check-ins and symptom trends will be captured to alert clinical teams early, potentially preventing complications and reducing acute care utilization.
"Navigating metastatic breast cancer is a daily reality that extends far beyond the four walls of the clinic," said Dr. Maen Farha of Avident Health LLC. "By combining the proactive digital coordination of MyNavigator with Unite for HER's exceptional integrative services and NCCN's gold-standard guidelines, we are creating a continuous circle of support that empowers patients, supports clinical teams, and actively engages the family caregivers who are vital to treatment success."
Sue Weldon, Founder and CEO of Unite for HER, added, "Collaborating with Avident Health on the MyNavigator platform enables us to reach patients and their families directly at the exact moment they need guidance, removing barriers to our integrative nutrition, wellness, and emotional support resources."
The project will measure quality improvement endpoints over the grant period, including improvements in patient knowledge concordance with NCCN Guidelines, rates of supportive service utilization, patient-reported decisional conflict, and therapy adherence metrics. This initiative matters because it addresses the critical need for continuous support for metastatic breast cancer patients, potentially improving outcomes and quality of life while reducing the burden on clinical teams. By leveraging digital tools to bridge communication gaps, the collaboration could serve as a model for integrating supportive care into oncology practice, ultimately benefiting patients, caregivers, and the healthcare system.
For more information, visit www.avidenthealth.com and www.uniteforher.org.
